These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27253998)

  • 1. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.
    Gillis NE; Taber TH; Bolf EL; Beaudet CM; Tomczak JA; White JH; Stein JL; Stein GS; Lian JB; Frietze S; Carr FE
    Endocrinology; 2018 Jun; 159(6):2484-2494. PubMed ID: 29750276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
    Bolf EL; Gillis NE; Barnum MS; Beaudet CM; Yu GY; Tomczak JA; Stein JL; Lian JB; Stein GS; Carr FE
    Horm Cancer; 2020 Feb; 11(1):34-41. PubMed ID: 31865591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
    Zhang X; Jeyakumar M; Bagchi MK
    J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
    Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
    Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
    Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
    Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells.
    Ichijo S; Furuya F; Shimura H; Hayashi Y; Takahashi K; Ohta K; Kobayashi T; Kitamura K
    PLoS One; 2014; 9(12):e116252. PubMed ID: 25548921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.
    Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R
    Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
    Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.
    Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S
    J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.
    Manzotti G; Torricelli F; Donati B; Sancisi V; Gugnoni M; Ciarrocchi A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):346. PubMed ID: 31395086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Thyroid Hormone Receptor β Action Stimulates Hepatocyte Proliferation in Male Mice.
    Hönes GS; Kerp H; Hoppe C; Kowalczyk M; Zwanziger D; Baba HA; Führer D; Moeller LC
    Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35038735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.
    Sar P; Peter R; Rath B; Das Mohapatra A; Mishra SK
    PLoS One; 2011; 6(6):e20861. PubMed ID: 21687737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
    Lee KC; Li J; Cole PA; Wong J; Kraus WL
    Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
    Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
    Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
    Kato Y; Ying H; Willingham MC; Cheng SY
    Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
    Araki O; Ying H; Furuya F; Zhu X; Cheng SY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.